06:59:42 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-29 Kvartalsrapport 2024-Q3
2024-08-30 Kvartalsrapport 2024-Q2
2024-05-31 Kvartalsrapport 2024-Q1
2024-05-29 Ordinarie utdelning POLAR 0.00 SEK
2024-05-28 Årsstämma 2024
2024-02-23 Bokslutskommuniké 2023
2023-11-24 Kvartalsrapport 2023-Q3
2023-09-08 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-26 Kvartalsrapport 2023-Q1
2023-05-17 Årsstämma 2023
2023-05-05 Ordinarie utdelning POLAR 0.00 SEK
2023-03-13 Extra Bolagsstämma 2022
2023-02-24 Bokslutskommuniké 2022
2022-11-25 Kvartalsrapport 2022-Q3
2022-08-26 Kvartalsrapport 2022-Q2
2022-05-27 Kvartalsrapport 2022-Q1
2022-05-06 Ordinarie utdelning POLAR 0.00 SEK
2022-05-05 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-27 Kvartalsrapport 2021-Q2
2021-05-28 Kvartalsrapport 2021-Q1
2021-05-06 Ordinarie utdelning POLAR 0.00 SEK
2021-05-05 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-11-27 Kvartalsrapport 2020-Q3
2020-08-28 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning POLAR 0.00 SEK
2020-06-30 Årsstämma 2020
2020-05-29 Kvartalsrapport 2020-Q1
2020-02-28 Bokslutskommuniké 2019
2020-02-14 Extra Bolagsstämma 2020
2019-10-23 Kvartalsrapport 2019-Q3
2019-07-24 Kvartalsrapport 2019-Q2
2019-05-07 Split POLAR 16:1
2019-04-26 Kvartalsrapport 2019-Q1
2019-03-19 Årsstämma 2019
2019-02-04 Ordinarie utdelning POLAR 0.00 SEK
2019-02-01 Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Polarcool är verksamt inom medicinteknik. Idag är bolaget inriktade mot att produkter och lösningar inriktade för skador inom sport och aktivitet. Störst fokus återfinns inom forskning och utveckling av produkter som används vid behandling av hjärnskador vid exempelvis boxning, rugby och amerikansk fotboll. Verksamhet innehas på global nivå, med störst närvaro inom den europeiska marknaden.
2021-11-17 09:51:00

English Premier League football club Leeds United have entered into an agreement with PolarCool AB (publ) for use of the PolarCap® System. The agreement marks an exciting breakthrough for PolarCool within a new country and new market. The English Premier League is arguably the most recognized sports league in the world and the agreement provides a good opportunity for the company's expansion into new markets.

Leeds United will use the PolarCap® System for an initial trial period from January 1[st] to May 31[st] with the aim to subsequently sign a commercial agreement. PolarCool established contact with Rishi Dhand and Robert Price, the Leeds United Club Doctor and Head of Medical Services respectively. Both of which evaluated the scientific background and the clinical evidence surrounding the PolarCap® System.

PolarCool's CEO Erik Andersson comments:

- The company's first agreement in the Premier League is undeniably yet another important milestone for PolarCool. Our ambition is for this to generate similar momentum in this market to that that took place in French rugby earlier this autumn. Attention to concussions in soccer has increased after UEFA's concussion awareness campaign, with the issue being further highlighted during this summer's Euro2020.

The agreement is a result of PolarCool's broader marketing strategy and focus on impactful markets such as the UK. Contact was established with Leeds through Jamie Bache, the company's representative for the UK. Jamie is a former elite rugby player and a former Sports Marketing Account Manager for Umbro and has strong contacts throughout the sports industry as well as in English soccer.

This information is information that PolarCool (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out herein, on November 17th, 2021.